These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16526207)

  • 1. Neoadjuvant therapy of rectal cancer.
    Breberina M
    Med Pregl; 2005; 58(3-4):117-22. PubMed ID: 16526207
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiotherapy for rectal cancer.
    Harewood GC; Wiersema MJ
    N Engl J Med; 2002 Jan; 346(2):137-8. PubMed ID: 11806384
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
    Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
    J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal cancer.
    Legoux JL; Lehur PA; Penna C; Calais G; Roseau G; Calan LD
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S43-2S51. PubMed ID: 17151562
    [No Abstract]   [Full Text] [Related]  

  • 5. Local excision for early rectal cancer in the era of neoadjuvant strategies.
    Tepetes K; Spyridakis ME
    Hepatogastroenterology; 2007 Sep; 54(78):1689-93. PubMed ID: 18019696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal methods for staging rectal cancer.
    Muthusamy VR; Chang KJ
    Clin Cancer Res; 2007 Nov; 13(22 Pt 2):6877s-84s. PubMed ID: 18006793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging in oesophageal cancer.
    Plukker JT; van Westreenen HL
    Best Pract Res Clin Gastroenterol; 2006; 20(5):877-91. PubMed ID: 16997167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer.
    Maretto I; Pomerri F; Pucciarelli S; Mescoli C; Belluco E; Burzi S; Rugge M; Muzzio PC; Nitti D
    Ann Surg Oncol; 2007 Feb; 14(2):455-61. PubMed ID: 17139456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarifying the TNM staging of rectal cancer in the context of modern imaging and neo-adjuvant treatment: 'y''u' and 'p' need 'mr' and 'ct'.
    Moran B; Brown G; Cunningham D; Daniels I; Heald R; Quirke P; Sebag-Montefiore D
    Colorectal Dis; 2008 Mar; 10(3):242-3. PubMed ID: 17498205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality for the data basis of evidence-based medicine: rectal cancer and preoperative 5 x 5 irradiation].
    Kornmann M; Henne-Bruns D
    Zentralbl Chir; 2008 Feb; 133(1):20-4. PubMed ID: 18278697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
    Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
    G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic surgery in rectal cancer: a prospective analysis of patient survival and outcomes.
    Bianchi PP; Rosati R; Bona S; Rottoli M; Elmore U; Ceriani C; Malesci A; Montorsi M
    Dis Colon Rectum; 2007 Dec; 50(12):2047-53. PubMed ID: 17906896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.
    Sloof GW
    Best Pract Res Clin Gastroenterol; 2006; 20(5):941-57. PubMed ID: 16997171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete clinical and pathological response to preoperative short course radiotherapy in T 2 rectal cancer.
    Selvasekar CR; Obeidat S; Simcock P; Khan AU
    Indian J Cancer; 2009; 46(4):350-1. PubMed ID: 19749473
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimizing preoperative management of rectal cancer.
    Hottenrott C
    World J Surg; 2011 Jun; 35(6):1416-7; author reply 1418-9. PubMed ID: 21191584
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Invasive rectal cancer treated by "neoadjuvant" radiochemotherapy: can we avoid rectal resection?].
    Ouaïssi M; Alves A; Panis Y
    Ann Chir; 2006 Mar; 131(3):175-6. PubMed ID: 16530720
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy.
    Habr-Gama A
    Colorectal Dis; 2006 Sep; 8 Suppl 3():21-4. PubMed ID: 16813588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.